Phase I clinical trial of HC-1119: A deuterated form of enzalutamide

Li, XY; Cheng, K; Li, XH; Zhou, YW; Liu, JY; Zeng, H; Chen, YW; Liu, X; Zhang, Y; Wang, YS; Bi, F; Zheng, L

Zheng, L (corresponding author), Sichuan Univ, West China Hosp, GCP Ctr, Inst Clin Pharmacol, Guoxuexiang 37, Chengdu 610041, Peoples R China.; Bi, F (corresponding author), Sichuan Univ, West China Hosp, Dept Abdominal Oncol, Guoxuexiang 37, Chengdu 610041, Peoples R China.

INTERNATIONAL JOURNAL OF CANCER, 2021; 149 (7): 1473